Lung Cancer and Asbestos Exposure - The Relationship



Similar documents
Clinical Study of Asbestos-Related Lung Cancer

Malignant Pleural Mesothelioma in Parts of Japan in Relationship to Asbestos Exposure

Uses and Abuses of Pathology in Asbestos-exposed Populations

Table 2.4. Summary of design and findings from mesothelioma case-control studies

Asbestos, Asbestosis, and Lung Cancer

NHS Barking and Dagenham Briefing on disease linked to Asbestos in Barking & Dagenham

Asbestos Health Risks. Dr Andrew Pengilley Acting Chief Health Officer

Influence of Fiber Type, Size, and Number in Human Disease: Conclusions from Fiber Burden Analysis

Scientific Update on Safe Use of Asbestos. Robert P. Nolan, PhD International Environmental Research Foundation New York, New York

Lung cancer and asbestos

HANDLING LUNG CANCER CLAIMS

How To Determine The Risk Of Mesothelioma In Brake Workers

HEALTH CARE FOR EXPOSURE TO ASBESTOS The SafetyNet Centre for Occupational Health and Safety Research Memorial University

Asbestos and Mesothelioma in Thailand

Defending the Rest Basics on Lung Cancer, Other Cancers and Asbestosis: Review of the B-Read and Pulmonary Function Testing

Call for an International Ban on Asbestos

Health effects of occupational exposure to asbestos dust

Producing Analytical Data, Microscopy and Analytical Procedures

Asbestos Diseases. What Is Asbestos?

Changing Trends in Mesothelioma Incidence. Hans Weill, M.D. Professor of Medicine Emeritus Tulane University Medical Center

Survey of Mesothelioma Associated with Asbestos Exposure in Japan

OCCUPATIONAL LUNG CANCER

Asbestos and Mesothelioma a briefing document for the Metropolitan Police

Asbestos related cancers

Primary -Benign - Malignant Secondary

Male. Female. Death rates from lung cancer in USA

Epidemiology of Malignant Mesothelioma An Outline

- Compensation issues

Occupational respiratory diseases due to Asbestos. Dirk Dahmann, IGF, Bochum

NISG Asbestos. Caroline Kirton

The Attribution of Lung Cancers to Asbestos Exposure A Pathologic Study of 924 Unselected Cases

Countermeasures for Asbestos at Ironworks

Health Effects of Asbestos Exposure

Malignant Mesothelioma Among Employees of a Connecticut Factory that Manufactured Friction Materials Using Chrysotile Asbestos

Asbestos Related Diseases

Mesothelioma among shipyard workers in Monfalcone, Italy

PATTERNS OF MORTALITY IN ASBESTOS FACTORY WORKERS IN LONDON*

Current Usage and Health Significance of the Modern Use of Chrysotile Products: Review of Recently Published Evidence

The Burden of Occupational Lung Cancer Paul A. Demers, PhD

Emerging evidence that the ban on asbestos use is reducing the occurrence of pleural mesothelioma in Sweden

Asbestos Related Diseases. Asbestosis Mesothelioma Lung Cancer Pleural Disease. connecting raising awareness supporting advocating

Lung Cancer. Public Outcomes Report. Submitted by Omar A. Majid, MD

WORKPLACE SAFETY AND INSURANCE APPEALS TRIBUNAL DECISION NO. 1557/14

Testimony of. Dr. James Crapo. April 26, 2005

Quantification of Non-Fibrous and Fibrous Particulates in Human Lungs: Twenty Year Update on Pneumoconiosis Database

Survey on the Mortality from Malignant Tumors of Female Asbestos Spinning Workers

ASBESTOS FIBRES IN THE LUNGS OF CHRYSOTILE MINERS AND MILLERS A PRELIMINARY REPORT

A. Sanden*, B. Jarvholm*, S. Larsson**, G. Thiringer*

EFFECT OF CHILDREN'S AGE AND LIFE EXPECTATION ON MESOTHELIOMA RISK 1

Review of Eliminating occupational cancer in Europe and globally by J. Takala

MORTALITY FROM LUNG CANCER IN ASBESTOS WORKERS

Future Trends of Mesothelioma Mortality in Japan Based on a Risk Function

How To Prevent Asbestos Related Diseases

Asbestos Disease: An Overview for Clinicians Asbestos Exposure

Disease/Illness GUIDE TO ASBESTOS LUNG CANCER. What Is Asbestos Lung Cancer? Telephone

Lung Cancer. This reference summary will help you better understand lung cancer and the treatment options that are available.

ASBESTOS DISEASES. Dr Alastair Robertson

An Update on Lung Cancer Diagnosis

Epidemiology, Staging and Treatment of Lung Cancer. Mark A. Socinski, MD

Mesothelioma in Australia: Incidence (1982 to 2013) and Mortality (1997 to 2012)

Mesothelioma mortality in Great Britain Summary 2. Overall scale of disease including trends 3. Region 6. Occupation 7

Occupational Disease Fatalities Accepted by the Workers Compensation Board

Asbestos Diseases Uncovered

Mesothelioma Incidence and Community Asbestos Exposure

Respiratory Conditions in Malaysian Asbestos Cement Workers

Worldwide mesothelioma mortality trends

Asbestos related health risks

Asbestos at the Work Site

Mesothelioma. 1. Introduction. 1.1 General Information and Aetiology

Malignant Mesothelioma

Malignant Mesothelioma

by Lee S. Newman, M.D., and Cecile S. Rose, M.D., M.P.H.

Mesothelioma Trends as Predictors of the Asbestos- Related Lung Cancer Burden

Mesothelioma. Mesothelioma and Asbestos 11/21/2009

The Carcinogenicity of Chrysotile Asbestos A Review

Toxicity of Amphibole Asbestos

PROTOCOL TO ASSESS ASBESTOS-RELATED RISK

Andrews Publications Tobacco Litigation 2000 THEORIES FOR THE REDUCTION OF DAMAGES

Lung Cancer Causes and Consequences

Determination of Asbestos Exposure by Pathology and Clinical History

Asbestos - Frequently Asked Questions

MESOTELIOMA and CHRYSOTILE

Update of the scientific evidence on asbestos and cancer. Kurt Straif, MD MPH PhD. The IARC Monographs

Science-Based Facts Relevant Health Issues For environmental occupational health safe and responsible use

Sir William Osler: Listen to the patient; the patient tells you everything.

between occupations and asbestos-fibre content of the lungs in patients with pleural

Mesothelioma: Questions and Answers

WA Asbestos Review Program

ROUND TABLE ADVANCES IN OCCUPATIONAL CANCER

Estimation of the Number of Lung Cancer Cases Attributable to Asbestos Exposure

Francine Lortie-Monette, MD, MSc, CSPQ, MBA Department of Epidemiology and Biostatistics University of Western Ontario 2003

June 20, : Wagner Testimony on Workplace Exposure to Asbestos. This is an archive page. The links are no longer being updated.

BY THE NUMBERS: THE FUTURE OF MESOTHELIOMA IN AMERICA

Naturally Occurring Asbestos (NOA) General Overview

Interstitial lung disease in a rheumatic electrician

Summary of Investigation into the Occurrence of Cancer Census Tract 2104 Zip Code 77009, Houston Harris County, Texas May 11, 2010

SUMMARY OF S.B. 15 ASBESTOS/SILICA LITIGATION REFORM BILL

Occupational Characteristics of Cases with Asbestosrelated Diseases in The Netherlands

Criteria for Attributing Lung Cancer to Asbestos Exposure

Asbestos: health effects and risk. Peter Franklin Senior Scientific Officer, EHD Senior Research Fellow, UWA

Transcription:

The Relationship Between Lung Cancer and Asbestos Exposure* Takumi Kishimoto, M.D.; and Keisei Okada, M.D. This study supports the theory that asbestos exposure may be implicated in a recent upsurge of terminal lung cancer cases in Kure, Japan. The number of asbestos bodies found in the lung during autopsy of 15 subjects from 194 to 196 suggests that 7.4 percent of the 51 diagnosed lung cancer cases could be attributed to asbestos exposure. Of the 17 subjects in whom death was not caused by cancer, 3.4 percent had significant asbestos exposure. Types of asbestos bodies found in diagnosed lung cancer cases were analyzed using scanning electron microscopy and x-ray analyzer. Chrysotile was the most widely found component, but amphiboles such as crocidolite and amosite also were detected. Residents of Kure had high exposure to the inhalation of asbestos bodies, possibly related to the upsurge in lung cancer deaths. In our earlier report, asbestos exposure was implicated in the increased incidence of malignant mesothelioma in Kure, an active Japanese shipbuilding port since the 192s. Our current findings indicate that asbestos exposure may be a pathogenic factor in lung cancer in world seaports where asbestos exposure has been prevalent. (Chest 19; 94:46-9) From 194 through 196, there was a significant increase in the rate of deatlh from lung cancer in Japan. This increase is particularly evident in the male population and in certain geographic areas including Kure, Japan. We previously reported a similar increase in the death rate from malignant mesothelioma and provided evidence for an etiologic relationship to asbestos exposure. In the current study, our data suggest that asbestos exposure may also be the underlying cause of the recent upsurge in lung cancer. MATERIAL AND METHODS In the three-year period from 194 to 196, autopsy was performed at Kure Kyosai Hospital on 15 patients who had resided in the city or suburbs of Kure, Japan. Fifty-one cases were of lung cancer and seven malignant mesothelioma, and 1 were noncancerous. The number of asbestos bodies iri the lung tissue of these 15 cases were counted by the modified method of Smith and Naylor.i Briefly, 1 g of lung tissue (inferior lobe without tumor involvement) was lysed in sodium hypochlorite for 4 hours. Asbestos bodies were separated by the use of equal volume (2 ml) ofchloroform (Wako) and 5 percent ethanol (Wako) and centrifuged at 1 g for five minutes. The bottom fraction was filtered on a 5- pm Millipore filter. Finally the number of asbestos bodies were counted on the filter by light microscopy (x 2). For cases with lung cancer, we recorded sex, age, histology, lateral involvement, originating lobe, smoking history, occupational history, and the duration of asbestos exposure. Detected asbestos bodies were coated with carbon, then analyzed by using scanning electron microscopy (T-33> JEOL) and x-ray analyzer (Seiko). The type of asbestos bodies was determined according the UICC standard reference23 For identification, we measured the types and percentages of metals in the asbestos bodies and determined the kind of asbestos bodies. We analyzed at least 2 asbestos bodies in each *From the Department of Clinical Investigation, Kure Kyosai Hospital, Kure, Japan. Manuscript received September ; revision accepted February 2. Reprint requests: Dr Kishimoto, 2-3-2 Nishichuo, Kure City, Japan 737 46 case. Asbestos bodies were also counted in noncancer cases; 15 cases of cerebral vascular accident (CVA), 27 myocardial infarction, eight tuberculosis of the lung, 21 liver cirrhosis, 1 pneumonia, and 11 others (two hypoplastic anemia, two sepsis, three renal failure, three diabetes mellitus, and one suicide). For control, we referred to the number of asbestos bodies found in autopsied lungs in other parts of Japan and estimated the baseline of the significant number of asbestos bodies per 1 g of lung tissue4,5 In this study we used nonparametric analysis using the Krushal-Wallis one-way analysis of variance and the multiple comparison method of Dun.6 RESULTS Figure 1 shows the number of asbestos bodies per gram of lung tissue in lung cancers, mesotheliomas, and noncancer patients. All patients withi malignant mesotheliomas had asbestos bodies numbering rpore than 5/g of lung tissue, whereas 36 of 51 (7.6 percent) patients with lung cancer had more than 1/g (up to 31,25/g). This is significantly (p<.1) higher than that of noncancer cases (3.6 percent). In the noncancer group there were 1 cases whose count of asbestos bodies exceeded 5/g. All of these cases had established occupational histories of asbestos exposure, but the other 36 patients did not have definite occupational histories of asbestos exposure. Figure 2 shows the classification of cases with lung cancer according to sex. Of the six cases in women, two had more than 1 asbestos bodies/g. By contrast, 75.6 percent of cases in men had rnore than 1 bodies/g. The difference is statistically significant (p<o.1). All of the men had occupational histories of asbestos exposure. Figure 3 classifies the cases of lung cancer according to histologic diagnosis: 21 cases of squamous cell carcinomna, 24 adenocarcinoma and large cell carcinoma, and six small cell carcinoma. The average number of asbestos bodies in the squamous cell type Downloaded From: http://publications.chestnet.org/ on 1/6/215

2 O 79135 o 52659 O 14 o 4 o 2356 o 3125 o 974 o 15514 O 1123 O 444 2669 14916 o 34 o 12225 O 3125 n 974 15514 1123 O 444 O 2669 o 215 51) a) v) v) s: 15 (I) W a) -o U) 5) (L Ul) n 1 D Q Q- 11) -o n 5 nu.r. -.,- -1-1 Non Cancer Lung Cancer Mesothel ioma n-1 n=51 n=7 FIGURE 1. Number of asbestos bodies per gram of lung tissue in cases without cancer and in patients who died from lung cancer and mesothelioma. Number of asbestos bodies in cases with lung cancer and mesothelioma is significantly higher (p<.1) than that of noncancer cases: lung cancer, 1,432 + 7,77; noncancer, 151 ± 2; mesothelioma, 37,11 + 19,723. was higher than those of other types, especially compared with the small cell type. Cases with right lung involvement (4,65±1 974) had more asbestos bodies than those of the left side (19,952 ±19,2), and those in the superior lobe (17,41 ± 13,33) more than inferior (69 ± 23). According to the smoking history of these 51 lung cancer patients, 36 were more than 4 by the Brinkman Index (BI).7 The women patients were not heavy smokers, but 7.6 percent of the men were heavy smokers. Occupational history indicated that 25 of these men worked in the Japanese naval shipyard before or during World War II. Another six patients had occupational histories in other shipyards. A total of 36 cases had definite history of asbestos exposure. The duration of asbestos exposure in these cases was six months to 4 years (average, nine years). Occurrence of death following initial exposure was 15 to 4 years (average, 27 years). Chrysotile was the major component ofasbestos bodies Uf) 12) n 5 b Cb X Cbc Male Female n=45 n=6 FIGURE 2. Distribution of lung cancer according to sex. The 6 cases in women had considerably fewer asbestos bodies than men. Occupational history in males may explain this difference. Male, 11,339 +,45; female, 129 + 79. detected in lung tissue of patients with lung cancer. Figure 4 shows typical results of analysis of an asbestos body found in a lung cancer case. According to the percentages of Mg, Ca, Fe, and Si, we determined this asbestos body to be chrysotile. Some crocidolites and amosites also were found. Ordinarily we would expect to find these three types of asbestos in the same patient, but chrysotiles were the main component found in 7 percent of patieints with lung cancer. DIscuSSION The incidence of lung cancer, which has recently increased in Japan, has shown a pronounced upsurge in specific regions such as Kure City in Hiroshima Prefecture, particularly in male patients (Table 1). CHEST / 94 / 3 / SEPTEMBER, 19 47 Downloaded From: http://publications.chestnet.org/ on 1/6/215

a) 44 V) 15 _ 1 44 -o V) tn 5- Q-o 'n 1l-1w n o 974 o 1122 O 444 o 215 CP U 3125 15514 o 2669 CP Squamous Adenocarcinoma Small cell carcinoma or cell carcinoma Large cell carcinoma n=21 n=24 n= 6 FIGURE 3. Distribution of lung cancer cases according to histology A higher number of asbestos bodies was seen in patients with squamous cell carcinoma and adenocarcinoma. There is a significant difference between squamous and small cell cases (p<.1). Squamous cell carcinoma, 6,121 + 4,675; adenocarcinoma, and large cell carcinoma 13,51 ± 12,65; small cell carcinoma, 14 ± 53. 1N-55/JXR-4 X-ray Analyser Cursor:.ReV = ROI SAn Japan is a major industrial country in which asbestos minerals have been utilized for about 5 years. Since the 192s, Kure's naval shipyards have been wellknown, and shipbuilding has continued in Kure and its suburbs since 1945. Most male residents over 7 years old have had at least some occupational connection with naval shipbuilding in Kure. We recently' documented that the recent upsurge of incidence of malignant mesothelioma could be related to asbestos exposure. This is consistent with several other reports'demonstrating asbestos exposure in shipyards.9"1 In the present study we extended our work to cancer of the lunig. We evaluated 51 cases of lung cancer on whom autopsy was done in an attempt to relate the appearance of cancer to asbestos exposure. To estimate the extent of asbestos exposure, we set a limit of 1 asbestos bodies/g of lung tissue as the baseline. This measurement is high enough to compare the volume of asbestos bodies detected in any Japanese person with asbestos exposure4"5 as well as to compare data with other reports.11"12 According to this criterion, 7.6 percent of patients with lung cancer had more than baseline asbestos exposure than 3.6 percent of noncancer patients. In addition, almost all of them had an occupational history of work in Japanese naval shipyards. 'Therefore, it is likely that asbe'stos exposure is an etiologic factor in the recent upsurge in lung cancer in Kure City These patients were also heavy cigarette smokers (BI more than 4), and smoking is thought to be an important factor in pathogenesis of asbestos-induced lung cancer.'134 The latency of lung cancer after FRI 12-DEfC-6 15:23 () 9.12: 9.43. =F 24 1 4 VFS S2t 1.24 5 PT NO-31 NEEDLE CRISIARL FIGURE 4. Typical analysis of an asbestos body from a lung cancer case. According to the UICC standard reference, we determined this body to be chrysotile. 4 Downloaded From: http://publications.chestnet.org/ on 1/6/215

Table 1-Cancer and Lung Cancer Mortality in Males Exposed to Asbestos in Kure, Japan, Compared with Other Parts ofjapan, 195-7 Kure Hiroshima Average, Year No. City Prefecture Japan 195 Total cancer cases in Kure 431 Lung cancer cases in Kure 7 3.5* 25.9* 23.3* Male: Total cancer cases 255 Lung cancer cases 5 44.7 37.2 34.6 Female: Total cancer cases 176 Lung cancer cases 2 17. 13.1 12.3 196 Total cancer cases in Kure 427 Lung cancer cases in Kure 73 31. 25. 23. Male: Total cancer cases 21 Lung cancer cases 5 51. 3. 35.3 Female: Total cancer cases 146 Lung cancer cases 15 12.7 14.1 12.7 *Per 1,. asbestos exposure is estimated to be more than 2 years.15 Our data were consistent with those of Bohlig and Otto.15 Three major kinds of asbestos bodies (chrysotile, crocidolite, and amosite) induce cancers. Amphiboles such as crocidolite and amosite are the major components of asbestos bodies thought to be involved in the pathogenesis of lung cancer. 16"17 Other articles describe chrysotile-induced lung cancer.1'9 Interestingly, chrysotile is the major component in our cases, and crocidolites and amosites were dominant in only 3 percent of cases with lung cancer. In all of our cases, chrysotile and amphiboles were mixed together in cases of lung cancer, a result consistent with that of the Howard report. 2 According to the histologic type, squamous cell carcinoma had a much higher incidence, and small cell types were rare in our series. Most cases originated on the right side, with higher incidence in the inferior lobe. Adenocarcinoma and inferior lobe origin were dominant in other reports of asbestos-induced lung cancer. 21-23 In long-term cigarette smokers, squamous metaplasia occurs and replaces the normal ciliary epithelium.24 The presence of smoking history in addition to chrysotile exposure could be responsible for this discrepancy Some investigators have indicated that the baseline number of asbestos bodies in 5 g lung tissue is less than 1.5,25-27 We think that this baseline is too low, and 1 per/1 gram lung tissue is a more realistic figure. Geographically Kure City is surrounded on three sides by mountains and on the fourth side by the Japan Inland Sea. Since the 192s, shipyards have been the major economic resource of the city and consequently exposure to asbestos has been universal. Because of the relative latency of asbestos-induced cancer, the upsurge in incidence of asbestos-induced cancer has been expected to peak in the 19s, and we think that the recent upsurge in lung cancer may be explained on this basis. REFERENCES 1 Smith MJ, Naylor B. A method for extracting ferruginous bodies from sputum and pulmonary tissue. Am J Clin Pathol 1972; 5:25-54 2 Timbrell XV Gilson JC, Webster I. UICC standard reference samples of asbestos. Int j Cancer 196; 3:46-3 Langer AM, Rubin IB, Selikoff IJ. Chemical characterization of asbestos body core by electron microprobe analysis. J Histochem Cytochem 1972; 2:723-34 4 Matsuda M. A study of the asbestos body: detection of the asbestos body from the autopsy lung. Jpn J Thorac Dis 1975; 13:4-43 5 Murai Y, Kitagawa M. The number of asbestos bodies from the autopsy lung in Hokuriku area, Japan. Lung Cancer 194; 24:239-45 6 Hollander M, Wolfe D. Nonparametric statistical methods. New York: John Wiley & Sons, 1973 7 Stevens RG, Moolgavkar SH. A cohort analysis of lung cancer and smoking in British males. Am J Epidemiol 194; 119:624-41 Kishimoto T, Okada K, Sato T, Ono T, Ito H. Evaluation of the pleural malignant mesothelioma patients with the relation of asbestos exposure. Environ Res (in press) 9 Selikoff IJ, Lilis R, Nicholson WJ. Asbestos disease in United States shipyards. Ann NY Acad Sci 1979; 33:295-311 1 Harries PG. Experience with asbestos disease and its control in Great Britain Naval dockyards. Environ Res 1976; 11:261-67 11 Bignon J, Goni J, Bonnaud G. Incidence of pulmonary ferruginous bodies in France. Environ Res 197; 3:43-42 12 Roggli XV Greenberg SD, Seitzman LH, McGavran MH, Hurst GA, Spivey CG, et al. Pulmonary fibrosis, carcinoma and ferruginous body counts in amosite asbestos workers. Am J Clin Pathol 19; 73:496-53 13 SelikofflJ, Hammond EC, Churg J. Asbestos exposure, smoking and neoplasia. JAMA 196; 24:16-12 14 Hammond EC, Selikoff IJ, Seidman H. Asbestos exposure, cigarette smoking and death rates. Ann NY Acad Sci 1979; 33:473-9 15 Bohlig H, Otto H. Asbest und Mesothelioma. Stuttgart: Thieme Verlag, 1975 16 Acherson ED, Garden MJ. Asbestos: final report of the advisory committee. London: HMSO, 1979 17 Royal Commission on Matters of Health and Safety, Canada. Report of the Royal Commission on Matters of Health and Safety arising from the use of asbestos in Ontario. Toronto: Ontario Ministry of Government Services, 194 1 Langer AM, Selikoff IJ, Sartre A. Chrysotile asbestos in the lungs of persons in New York City Arch Environ Health 1971; 22:34-61 19 Acherson ED, Gardner MJ. Asbestos: the control limit for asbestos: an update of the relevant sections of the ill effects of asbestos upon health. Health and Safety Commission. London: HMSO, 193 2 Howard JK. Relative cancer risks from exposure to different asbestos fibre types. N Z Med J 194; 26:646-49 21 Kannerstein M, Churg J. Pathology of carcinoma of the lung associated with asbestos exposure. Cancer 1972; 3:14-21 22 Warnock ML, Churg AM. Association of asbestos and bronchogenic carcinoma in a population with low asbestos exposure. Cancer 1975; 35:1236-42 23 Rufie P Etiological and histological study of 44 cases of lung cancer. Ann Intern Med 191; 132:12-1 CHEST / 94 / 3 / SEPTEMBER, 19 49 Downloaded From: http://publications.chestnet.org/ on 1/6/215

24 Woodworth CD, Mossman BT, Craighead JE. Squamous metaplasia of the respiratory tract-possible pathogenic role in asbestos-associated bronchogenic carcinoma. Lab Invest 193; 4:57-4 25 Rosen PE Melamed M, Savino A. The "ferruginous body" content of lung tissue: a quantitative study of eighty-six patients. Acta Cytol (Baltimore) 1972; 16:27-11 26 Sera Y, Konishiike J. The detection of asbestos bodies in the lung at random autopsies and surgical pulmonary resection. Iryo 1974; 3:1125-31 27 Churg A, Warnock ML. Correlation of quantitative asbestos body counts and occupation in urban patients. Arch Pathol 1977; 11:629-3 AMA National Conference on Impaired Health Professionals: Visions and Values The American Medical Association will present this conference, co-sponsored by other health professional organizations, at the Chicago Marriott Hotel, October 26-3. The purpose of the conference is to encourage development of programs that include the major components of prevention, education, case-finding, intervention, treatment referral, aftercare/monitoring and re-entry/retraining to encourage an increased level of fuinding for such comprehensive programs; and to better help those programs provide rehabilitative help while ensuring public safety The conference will bring together the varying disciplines and organizations concerned with the impairment and well-being of health professionals and to stimulate the creation of working relationships among these based on common concerns and mutual respect so as to better utilize existing resources. In addition, the conference will provide a forum for the interchange of ideas and approaches that can be replicated to help programs function more effectively The conference welcomes anyone involved, or wishing to become involved, in programs to identify, treat, rehabilitate or discipline health professionals suffering from alcoholism, drug dependence, psychiatric illness or other potentially impairing problems, such as hospital administrators, risk managers, and medical staff coordinators; licensing board members, staff, investigators; deans/faculty members from medical and dental schools, etc; residency training directors/programs directors and staff/professionals in training; spouses of physicians and other health professionals; professionals in recovery; treatment providers. For information, contact the AMA Department of Registration Services, 535 North Dearborn Street, Chicago 661 (-621-335). 49 Downloaded From: http://publications.chestnet.org/ on 1/6/215